Acceptability of the NuvaRing Among Students

• Status: Completed
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: Female

Summary

The ACCEPT study is a Phase IV trial in which women are randomized to either the NuvaRing® vaginal contraceptive ring or a low dose oral contraceptive to assess compliance, side effects, overall acceptability and intent to continue use of the method. The study is focused on the acceptability of the vaginal ring among female undergraduate or graduate students.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Chicago
• Collaborator: Organon
• Treatments: Contraceptive Agents; Contraceptives, Oral; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Fluoroquinolones; Moxifloxacin; Norgestimate, ethinyl estradiol drug combination; NuvaRing

Criteria

Inclusion Criteria:

• over 18

• student enrolled in college or graduate program

• Not have used the contraceptive patch or oral contraceptives within the last month

• Never have used a contraceptive vaginal ring

• Interested in using hormonal contraceptives, specifically NuvaRing and oral contraceptive pills for next 3 months

• In general good health

• Premenopausal with the ability to menstruate

Exclusion Criteria:

• Known or suspected pregnancy

• Pregnancy within 2 months of trial medication

• Past use of any contraceptive vaginal ring

• Hypersensitivity or allergy to NuvaRing or Oral Contraceptives

• Use of investigational drug within 2 months of start of trial medication

• Use of the contraceptive patch or oral contraceptives within past month

• Use of any injectable contraception within 6 months of trial medication

• Planning pregnancy in next 6 months